Shares of Humana Inc. (NYSE:HUM – Get Free Report) hit a new 52-week high during trading on Thursday after Evercore raised their price target on the stock from $250.00 to $370.00. The stock traded as high as $369.34 and last traded at $365.8880, with a volume of 959547 shares trading hands. The stock had previously closed at $363.18.
Several other brokerages have also commented on HUM. Jefferies Financial Group raised Humana from a “buy” rating to a “buy” rating in a research note on Wednesday, May 20th. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $425.00 price target on shares of Humana in a research note on Wednesday, June 3rd. Seaport Research Partners lowered Humana to a “neutral” rating in a research note on Wednesday, May 20th. The Goldman Sachs Group boosted their price target on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research note on Thursday, April 30th. Finally, Mizuho boosted their price target on Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, fifteen have assigned a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and a consensus target price of $291.35.
Check Out Our Latest Report on Humana
Hedge Funds Weigh In On Humana
Humana Trading Up 2.9%
The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The firm has a market cap of $45.55 billion, a price-to-earnings ratio of 40.58, a price-to-earnings-growth ratio of 2.10 and a beta of 0.76. The business’s fifty day moving average is $267.90 and its two-hundred day moving average is $237.20.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. Humana’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same quarter last year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts anticipate that Humana Inc. will post 9.04 earnings per share for the current fiscal year.
Humana Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio is 37.86%.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Further Reading
- Five stocks we like better than Humana
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
